| Literature DB >> 34277052 |
Elodie Berg1, Leslie Madelaine1, Jean-Marc Baste2, Marcel Dahan3, Pascal Thomas4, Pierre-Emmanuel Falcoz5, Emmanuel Martinod6, Alain Bernard1, Pierre-Benoit Pagès1.
Abstract
BACKGROUND: Anatomical segmentectomy is an alternative to lobectomy for early-stage lung cancer (LC) or in patients at high risk. The main objective of this study was to compare the morbidity and mortality associated with these two types of pulmonary resection using data from the French National Epithor database.Entities:
Keywords: Segmentectomy; early-stage lung cancer (early-stage LC); lobectomy; mortality; postoperative complications
Year: 2021 PMID: 34277052 PMCID: PMC8264688 DOI: 10.21037/jtd-20-2203
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Unmatched patient baseline characteristics
| Patient characteristics | Segmentectomy (n=1,604) | Lobectomy (n=14,786) | P Value |
|---|---|---|---|
| Gender | |||
| Male | 972 (61%) | 9,595 (65%) | 0.001 |
| Female | 632 (39%) | 5,191 (35%) | |
| Age (Years) | 66±9 | 64±10 | 0.00001 |
| Medical History | |||
| Chronic bronchitis | 466 (29%) | 3,139 (21%) | 0.0001 |
| Smoker | 365 (23%) | 3,760 (25%) | 0.02 |
| Chronic heart failure | 45 (3%) | 301 (2%) | 0.04 |
| Alcoholism | 99 (6%) | 740 (5%) | 0.04 |
| Neurological disease | 16 (1%) | 204 (1.4%) | 0.2 |
| Anemia | 1 (0.6%) | 35 (0.24%) | 0.15 |
| Hematological disease | 42 (2.6%) | 255 (1.7%) | 0.01 |
| Cancer history | 613 (38%) | 4,225 (28%) | 0.0001 |
| Thoracotomy history | 244 (15%) | 988 (6.7%) | 0.0001 |
| Chronic respiratory failure | 142 (9%) | 856 (5.8%) | 0.0001 |
| ASA score | |||
| 1 | 308 (19%) | 2,370 (16%) | 0.0001 |
| 2 | 739 (46%) | 7,699 (52%) | |
| ≥3 | 557 (35%) | 4717 (32%) | |
| Performance status | |||
| 0 | 827 (51.5%) | 7,337 (50%) | 0.002 |
| 1 | 611 (38%) | 6,202 (42%) | |
| ≥2 | 166 (10.5%) | 1,247 (8%) | |
| Body mass index | |||
| <24 Kg/m2 | 695 (43%) | 6,634 (45%) | 0.16 |
| 24 to 28 Kg/m2 | 435 (27%) | 4,114 (28%) | |
| >28 Kg/m2 | 474 (30%) | 4,038 (27%) | |
| Forced expiratory volume (%) | 82±20 | 85±20 | 0.00001 |
| Surgical Management | |||
| VATS | 942 (59%) | 6,121 (41%) | 0.0001 |
| Hospital characteristics | |||
| Hospital volume | 226±236 | 208±197 | 0.0005 |
| Type | |||
| Non-teaching hospital | 171 (11%) | 1,325 (9%) | 0.04 |
| Private hospital | 551 (34%) | 5,006 (34%) | |
| Teaching hospital | 876 (55%) | 8,441 (57%) | |
| Postoperative pathological tumour characteristics | |||
| Stage | |||
| I | 906 (56%) | 5,850 (40%) | 0.0001 |
| II | 278 (17%) | 4,465 (30%) | |
| III | 82 (5%) | 1,842 (12%) | |
| IV | 47 (3%) | 448 (3%) | |
| Missing | 291 (18%) | 2,181 (15%) | |
| Lymph node involvement | |||
| N0 | 1,139 (71%) | 9,393 (63.5%) | 0.0001 |
| N1 | 72 (4.5%) | 1,470 (10%) | |
| N2 | 65 (4%) | 1,671 (11%) | |
| Missing | 328 (20.5%) | 2,252 (15%) | |
| Quality of resection | |||
| R0 | 1,273 (79.4%) | 12,289 (83%) | 0.0001 |
| R1 | 18 (1%) | 291 (2%) | |
| R2 | 9 (0.6%) | 57 (0.4%) | |
| Missing | 304 (20%) | 2,149 (14.6%) | |
Patients’ baseline characteristics after kernel matching with their standardized difference
| Patient characteristics | Segmentectomy (n=1,594) | Lobectomy (n=14,477) | P value | Standardized difference |
|---|---|---|---|---|
| Gender | ||||
| Female | 39% | 39% | 0.9 | 0.002 |
| Age (minus mean) (years) | 1.11 | 1.08 | 0.9 | 0.003 |
| Medical history | ||||
| Chronic bronchitis | 29% | 29% | 0.9 | 0.003 |
| Smoker | 23% | 23% | 0.9 | 0.002 |
| Chronic Heart failure | 3% | 2% | 0.9 | 0.003 |
| Alcoholism | 6% | 6% | 0.9 | 0.003 |
| Neurological disease | 1% | 1% | 0.9 | −0.005 |
| Hematological disease | 2.6% | 2.7% | 0.9 | −0.004 |
| Cancer history | 38% | 38% | 0.8 | 0.009 |
| Thoracotomy history | 15% | 15% | 0.7 | 0.015 |
| Chronic respiratory failure | 9% | 9% | 0.9 | 0 |
| ASA score | ||||
| 2 | 46% | 47% | 0.7 | −0.012 |
| ≥3 | 35% | 34% | 0.9 | 0.006 |
| Performance status | ||||
| 1 | 38% | 38% | 0.9 | −0.001 |
| ≥2 | 166 (10.5%) | 1247 (8%) | 0.9 | 0.002 |
| Body mass index | ||||
| 24 to 28 Kg/m2 | 27% | 27% | 0.9 | 0.004 |
| >28 kg/m2 | 29% | 29% | 0.9 | 0 |
| Forced expiratory volume (%)$ | 0.045 | 0.045 | 0.9 | 0 |
| Surgical management | ||||
| VATS | 58.5% | 59% | 0.6 | −0.017 |
| Hospital characteristics | ||||
| Hospital volume (minus mean) | 16 | 14.7 | 0.8 | 0.008 |
| Type | ||||
| Teaching hospital | 55% | 55% | 0.9 | −0.003 |
| Postoperative pathological tumour characteristics | ||||
| Stage | ||||
| II | 17% | 17% | 0.7 | 0.012 |
| III | 5% | 5% | 0.7 | 0.008 |
| IV | 3% | 3% | 0.7 | 0.011 |
| Missing | 18% | 19% | 0.7 | −0.012 |
| Lymph node involvement | ||||
| N1 | 4.5% | 4% | 0.8 | 0.006 |
| N2 | 4% | 4% | 0.8 | 0.006 |
| Missing | 20% | 20% | 0.9 | −0.002 |
| Quality of resection | ||||
| R1 | 1% | 1% | 0.8 | 0.005 |
| R2 | 0.5% | 0.5% | 0.9 | 0.004 |
| Missing | 19% | 19.6% | 0.7 | −0.013 |
A standardized difference greater than 0.1 (10%) represents meaningful imbalance in a given variable between treatment groups. $, polynomial transformation: X=FEV/100X−0.5−1.08
Figure 1Standardized differences of covariates before and after matching.
Comparison of outcome variables in segmentectomy vs. lobectomy in kernel matched sample
| Segmentectomy (n=1,594) | Lobectomy (n=14,477) | OR (95% CI) | P value | |
|---|---|---|---|---|
| Postoperative complications | ||||
| Atelectasis | 2.5% | 4.4% | 0.54 (0.4–0.75) | 0.0001 |
| Prolonged air leak (>5 days) | 7.8% | 9.8% | 0.75 (0.64–0.89) | 0.001 |
| Broncho-pleural fistula | 0.19% | 0.5% | 0.35 (0.14–0.83) | 0.017 |
| Pneumonia | 4.7% | 6.2% | 0.72 (0.55–0.95) | 0.02 |
| Haemorrhage | 1.2% | 1.5% | 0.79 (0.5–1.24) | 0.3 |
| Empyema | 0.25% | 0.48% | 0.5 (0.14–1.76) | 0.3 |
| At least one complication | 27% | 34% | 0.7 (0.62–0.78) | 0.0001 |
| Clavidien-Dindo Classification | ||||
| IIIa or IIIb or IVa or IVb or V | 4.6% | 8.5% | 0.5 (0.36–0.68) | 0.0001 |
| IVa or IVb or V | 2.7% | 4.9% | 0.52 (0.37–0.74) | 0.0001 |
| Postoperative mortality | ||||
| 30-day mortality | 1% | 1.3% | 0.67 (0.38–1.2) | 0.18 |
| 60-day mortality | 1.4% | 1.7% | 0.78 (0.42–1.47) | 0.4 |
| 90-day mortality | 1.6% | 1.9% | 0.77 (0.45–1.34) | 0.36 |